NCT07152067View on ClinicalTrials.gov

Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 1, 2030

Study Completion Date

September 1, 2033

Conditions
Macroscopic Tumor Visualized at MRITumor Size Allowing Partial Prostate Treatment VolumeCAPRA SCORE ≤5
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT)

SBRT to the macroscopic prostate tumor component defined at MRI

Trial Locations (2)

4000

University Hospital Liège, Liège

6700

Vivalia Hospitals, Arlon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Liege

OTHER